Ophthalmology CRO Services
KCAS Bio has experience in preclinical ophthalmic research, ranging from identification and procurement of compounds to determining efficacy, tolerability, and PK studies. We give you the milestone data you need to make important decisions in the early stages of your ophthalmologic product development.
Complex ophthalmology studies demand specialist expertise
When developing products for the eye, your project needs a CRO with specialist experience and expertise. Many studies in ophthalmology are complex, and for this reason you need a team which understands the assessments and can focus on the details. KCAS Bio knows how to provide high quality data for your ophthalmology drug development project.
Ophthalmology treatment research, by leading scientists
There are a couple major challenges typically associated with ophthalmology as it relates to bioanalysis, one of the main being limited access to fluids or tissues from a living eye. It is difficult to develop highly sensitive methods when you can’t use a lot of the matrix available. At KCAS Bio, we have a rich history of conducting studies on eye tissues and using unique techniques that make a little sample go a long way in our processes. We have leveraged our rich history of knowing how to build a sensitive method with a minimal amount of volume. Additionally, our pharma team has become well-known for their PK analysis of small molecules, which makes us a perfect candidate for ophthalmological studies, as typically the treatment of the eye is a small molecule.
We employ rigorous quality practices that go beyond our competition. Processes are continuously improved to ensure we consistently deliver a complete outsourcing experience to clients.
KCAS Bio provides high quality science and data services that have benefits for the entire drug development journey.
Agile, responsive, and easy to work with
We prepare and adapt our ophthalmology research based on a deep understanding of your drug development ambitions and wider business objectives.
KCAS Bio scientific insights
Blogs
Poster Title: Method Development and Validation for the Determination of Two Protein Biomarkers by Multiplexed Online and Offline Hybrid LC-MS/MS in Human Heart Tissue Can you explain your role at KCAS Bio? I am a Scientist 1 at KCAS Bio in the Mass Spectrometry Bioanalysis Method Development group. In…
Blogs
Receptor Occupancy (RO) assays by flow cytometry are a powerful tool for evaluating the extend of drug binding to its cell surface target, but they can also be challenging to design and execute well. Here’s a quick guide to the fundamentals, the common pitfalls, and what separates a strong study design from a risky one. What Is Receptor Occupancy? CAR-T therapies are living, and dynamic therapies; once…
Events
October 19
- October 21
KCAS Bio at the World Vaccine Congress – Europe 2026 KCAS Bio is thrilled to announce our participation in the World Vaccine Congress Europe, taking place in Amsterdam, Netherlands, from October 19-21. This event gathers the world’s leading vaccine research, development, and manufacturing experts to share groundbreaking insights and…
Tell us how we can help with your project
We've earned our reputation for delivering reliable, error-free data. We understand the importance of speed, flexibility, and consistency and only make promises we can keep.